According to AlphaMoat, in 2026-08 NewLimit (newlimit.com) received 14,861 monthly visits (+24.6% MoM) — ranked #8,560 of 17,407 AI websites with traffic data, and #1,214 of 3,173 in Industry Services; its largest market is United States (92.2% of visits).
Monthly Visits · 2026-08
14.9K+24.6%
Overall Rank (17,407)
#8,560
Industry Services Rank (3,173)
#1,214
Top Market
United States92.2%
What is NewLimit
Product Overview
NewLimit is dedicated to dramatically extending human healthspan, inventing medicines that can reverse cellular aging and restore youthful function.
Key Features2 items
01The platform centers on epigenetic reprogramming, activating transcription-factor genes to reprogram the epigenome to a youthful state
02it also builds frontier intelligence and experiment systems, using AI to design payloads that make old cells young, then tests thousands of designs simultaneously with genomics and iteratively trains models, ultimately advancing first-in-class therapies for aging-related diseases
12-Month Traffic Trend
Hover for monthly values
Latest 14.9KMoM+24.6%
2026-06
28.7K
—
2026-07
11.9K
-58.4%
2026-08
14.9K
+24.6%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
13,70992.2%
India
8725.9%
Vietnam
1971.3%
Germany
840.6%
Popular in Industry Services
Click for details, or "+ Compare" to compare with NewLimit
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.